Turkish Journal of Hematology Volume: 33 - Issue: 4

More documents

Recommendations

Info

Turk J Hematol 2016;33:273-280 Tombak A, et al: Azacitidine and Elderly Acute Myeloid Leukemia Patients affected survival. Statistical analyses were performed with PASW v.18 software (Predictive Analytics Software is a registered trademark of SPSS Inc.), and p0% 94 (72.3) Unknown 29 (22.3) Median (range), % 15 (0-90) Bone marrow blasts, n (%) 20%-30% 36 (27.7) >30% (off-label use) 80 (61.5) Unknown 14 (10.8) Median (range), % 49.5 (20-97) WBC count (10 9 /L), n (%) ≤10x10 9 /L 77 (59.2) >10x10 9 /L 53 (40.8) Median (range), % 4.9 (0.7-146) ANC (10 9 /L), median (range) 1.1 (0.05-142.7) Hb (g/L), median (range) 8.7 (4.2-14) Platelet count (10 9 /L), median (range) 57 (5-786) LDH (IU/L)
Tombak A, et al: Azacitidine and Elderly Acute Myeloid Leukemia Patients Turk J Hematol 2016;33:273-280 Table 1. Continuation MRC cytogenetic risk, n (%) Not evaluable 14 (10.7) Good 58 (44.6) Intermediate 56 (43.1) High 1 (0.8) Comorbidities, n (%) 66 (50.8) Number of comorbidities, n (%) 7 (5.4)
Page 1 and 2: Volume 33 Issue 4 December 2016 80
Page 3 and 4: Contact Information Editorial Corre
Page 5 and 6: TURKISH JOURNAL OF HEMATOLOGY INSTR
Page 7 and 8: should include a conclusion, in whi
Page 9 and 10: as appropriate, and then click the
Page 11 and 12: 335 Evaluation of Insulin-like Grow
Page 13 and 14: 6 th International Congress on Leuk
Page 15 and 16: Kesik V, et al: Prognostic Markers
Page 23: Tombak A, et al: Azacitidine and El
Page 27 and 28: Tombak A, et al: Azacitidine and El
Page 29 and 30: Tombak A, et al: Azacitidine and El
Page 31 and 32: Malkan ÜY, et al: The Prognosis of
Page 33 and 34: Malkan ÜY, et al: The Prognosis of
Page 35 and 36: RESEARCH ARTICLE DOI: 10.4274/tjh.2
Page 37 and 38: Ghasemi M, et al: Identification of
Page 43 and 44: Yorulmaz G, et al: Hyperparathyroid
Page 49 and 50: Kahlon P, et al: Therapeutic Intern
Page 51 and 52: Kahlon P, et al: Therapeutic Intern
Page 55 and 56: Işlak Mutcalı S, et al: Early Cha
Page 61 and 62: Çalık Başaran N, et al: Infectio
Page 71 and 72: Terzi YK, et al: HFE Mutations and
Page 73 and 74: Terzi YK, et al: HFE Mutations and
Page 75 and 76:
RESEARCH ARTICLE DOI: 10.4274/tjh.2
Page 77 and 78:
Baytan B, et al: Emotional Status a
Page 79 and 80:
Baytan B, et al: Emotional Status a
Page 81 and 82:
Ishibashi M, et al: CBFA2T3-GLIS2 F
Page 83 and 84:
Ishibashi M, et al: CBFA2T3-GLIS2 F
Page 85 and 86:
Ayer M, et al: Evaluation of IGF-1
Page 87 and 88:
Ayer M, et al: Evaluation of IGF-1
Page 89 and 90:
Patıroğlu T and Akar HH; HLA (A,
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
BRIEF REPORT DOI: 10.4274/tjh.2016.
Page 97 and 98:
Düzgöl M, et al: Varicella Infect
Page 99 and 100:
Jain M, et al. Chediak-Higashi Synd
Page 101 and 102:
Pradhan S: Auer Rod-Like Inclusions
Page 103 and 104:
Milosevic I: Coexistence of Chronic
Page 105 and 106:
LETTERS TO THE EDITOR Turk J Hemato
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
LETTERS TO EDITOR Turk J Hematol 20
Page 119 and 120:
LETTERS TO EDITOR Turk J Hematol 20
Page 121 and 122:
33 rd Volume Index / 33. Cilt Dizin
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129:
show all

Turkish Journal of Hematology Volume: 33 - Issue: 4

Create successful ePaper yourself

Delete template?

Save as template?